why choose us

300×250 Ad Slot

Research Article: The TUITEK® patient support program improved caregiver-related behaviors on growth hormone treatment adherence

Date Published: 2025-04-28

Abstract:
Background: Recombinant human growth hormone (r-hGH) can improve or normalize growth outcomes in pediatric patients with growth hormone deficiency, but poor adherence to the treatment regimen limits treatment effectiveness. TUITEK® is a multicomponent patient support program (PSP) designed to deliver support aimed at behavior change that is personalized to the needs of individual caregivers and patients throughout the treatment care pathway. The aim was to assess the impact of the TUITEK® PSP on knowledge, beliefs and perceptions of adherence to r-hGH treatment in high-risk caregivers.

No summary available.

300×250 Ad Slot